The Latest from
The Initiative
Clinical Trials
The Phase 2 Gene Therapy to Reduce All Sickle Pain (GRASP) Clinical Trial has launched
News + Updates
UCLA researcher receives NIH grant to develop a more affordable gene therapy for sickle cell disease
December 16, 2020
